Tag: 2024 ASCO Annual Meeting

innovent-announces-data-from-pivotal-phase-2-trust-i-study-of-taletrectinibros1-inhibitor-are-published-in-the-jco-and-reported-at-2024-asco-annual-meeting-thailand-business-news

Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib?ROS1 Inhibitor) are Published...

Innovent Biologics Reveals Breakthrough Data from Phase 2 TRUST-I Study of Taletrectinib at 2024 ASCO Annual MeetingSAN FRANCISCO, U.S. and SUZHOU, China - Innovent...

BREAKING NEWS

Random News

Most Read News